NCT01077973View on ClinicalTrials.gov

Study Evaluating A Novel Ibuprofen Formulation In Episodic Tension-Type Headache

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Pain

Interventions

DRUG

Novel Ibuprofen

Single-dose of novel ibuprofen (equal to 400 mg ibuprofen) plus placebo

DRUG

Standard Ibuprofen

Single-dose of standard ibuprofen (400mg) plus placebo

DRUG

Placebo

Single-dose of placebo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY